论文部分内容阅读
目的观察舒血宁注射液治疗冠心病心绞痛的临床疗效和安全性。方法对98例心绞痛患者随机单盲分为治疗组46例,给予舒血宁加硝酸甘油治疗;对照组42例,给予硝酸甘油治疗。结果治疗组、对照组总有效率分别为95.65%、59.52%,两组比较差异有统计学意义(P<0.05)。两组心电图改善总有效率为69.56%、38.09%,差异有统计学意义(P<0.05)。结论舒血宁加硝酸甘油治疗绞痛疗效显著,安全,无明显毒副作用。
Objective To observe the clinical efficacy and safety of Shuxuening Injection in treating angina pectoris of coronary heart disease. Methods A total of 98 patients with angina pectoris were randomly divided into treatment group (46 cases) and Shuxuening plus nitroglycerin (42 cases). Patients in the control group received nitroglycerin treatment. Results The total effective rates of the treatment group and the control group were 95.65% and 59.52%, respectively, with significant difference between the two groups (P <0.05). The total effective rate of two groups was 69.56%, 38.09%, the difference was statistically significant (P <0.05). Conclusion Shuxuening plus nitroglycerin treatment of colic significant effect, safe, no obvious side effects.